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ABSTRACT 
The present study was designed to evaluate the effect of fenugreek on isoproterenol (ISO) induced myocardial infarction in experimental rats. Male Wistar 
albino rats were divided into four groups (n=6). Group 1 rats served as control. Group 2 rats received isoproterenol (85 mg/kg body weight) intraperitoneally 
(i.p.) for 14
th and 15
th days. Group 3 rats received fenugreek (250 mg/kg body weight) via intragastric intubation for 15 days. Group 4 rats received fenugreek 
as in group 3 and additionally isoproterenol was given for 14
th and 15
th days.  ISO induced myocardial infarction was confirmed by disturbances in serum and 
heart tissue marker enzymes such as lactate dehydrogenase (LDH), creatine kinase (CK), CK-MB, aspartate transaminase (AST) and alanine transaminase 
(ALT), increased levels of serum lipoproteins like VLDL, LDL and decrease in HDL, increased levels of serum lipid metabolism like triglycerides (TG), free 
fatty acids (FFA), and cholesterol (CHO). In rats pretreated with fenugreek, the level of marker enzymes, lipoproteins and the activity of lipid metabolisms 
like TG, FFA and CHO were maintained at near normal values. Pretreatment with fenugreek offered a protective effect against ISO induced myocardial 
damage in rats as evidenced by comparing with control rats. These salubrious effect observed in this study might be due to the membrane stabilizing potential 
of fenugreek on ISO induced myocardial infarction in rats. 
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INTRODUCTION 
Cardiovascular diseases (CVDs) remain the principal cause 
of  death  in  both  developed  and  developing  countries, 
accounting for roughly 20% of all worldwide deaths per year. 
Cardiovascular diseases in India cause 3 million deaths per 
year, accounting for 25% of all mortality. The World Health 
Organization predicts that deaths due to circulatory system 
diseases are projected to double between 1985 and 2015
1. It 
is well known that CVD are directly or indirectly related to 
oxidative  damage  that  shares  a  common  mechanism  of 
molecular  and  cellular  damage.  Myocardial  infarction  or 
heart attack is the leading cause of death for both men and 
women all over the world. It occurs when blood supply is 
insufficient to the myocardium, death of myocardial muscle 
occurs, a condition known as ischemia. Prolonged ischemia 
of  the  myocardium  leads  to  necrosis,  which  is  referred  as 
myocardial infarction
2. It occurs when myocardial ischemia 
surpasses  the  critical  threshold  level  for  an  extended  time 
resulting  in  irreversible  myocardial  cell  damage.  Although 
clinical  care  is  improved,  public  awareness  is  raised  and 
health innovations are widely used, myocardial infarction still 
remains the leading cause of death worldwide
3. 
Isoproterenol (ISO), a synthetic b-adrenoceptor agonist, has 
been found to induce myocardial injury in rat as a result of 
disturbance in physiological balance between production of 
free radicals and antioxidative defense system
4, 5. It produces 
myocardial  necrosis  which  caused  cardiac  dysfunction, 
increased  lipidperoxidation  along  with  an  increase  in  the 
level  of  myocardial  lipids,  altered  activities  of  the  cardiac 
enzymes  and  antioxidants
6,  7.  It  is  the  acute  condition  of 
myocardial  necrosis  which  causes  cardiac  dysfunctions, 
increased  lipid  peroxidation,  altered  activities  of  cardiac 
enzymes and antioxidants
8. 
Free  radicals  and  reactive  oxygen  species  have  been 
implicated in large number of diseases and have a deleterious 
effect on heart functioning. Various experimental and clinical 
studies have shown that enormous amount of reactive oxygen 
species such as, superoxide, hydrogen peroxide and hydrogen 
radicals are generated in failing myocardium
7.  
Many plant species and their constituents are used in Indian 
Ayurvedic  Medicine  for  the  treatment  of  myocardial 
infarction. Recently, there renewed interest in medicinal plant 
and food products derived from medicinal plants that have 
been found to have certain preventive action in the treatment 
of  cardiovascular  diseases  (CVD).  Fenugreek  (Trigonella 
foenum  graecum)  belongs  to  the  leguminosae  family  and 
cultivated  predominantly  in  India,  the  Mediterranean  and 
North African regions. Fenugreek is known to have several 
pharmacological  effects  such  as  hypoglycemia,
9 
hypocholesterolemia,
10  chemopreventive,
11  anti-oxidant,
12 
antipyretic  and  anti-inflammatory  effects
13.  The  seeds  of 
fenugreek  contain  lysine  and  L-tryptophan  rich  proteins, 
mucilaginous fiber and other rare chemical constituents such 
as  saponins,  coumarin,  fenugreekine,  nicotinic  acid, 
sapogenins,  phytic  acid,  scopoletin  and  trigonelline,  which 
are thought to account for many of its presumed therapeutic 
effects. In this study, we examined the protective effects of 
fenugreek  against  isoproterenol  induced  myocardial 
infarction in rats.  
MATERIALS AND METHODS 
Chemicals 
Isoproterenol  was  obtained  from  the  Sigma  Chemical 
Company, St. Louis, MO, USA. All the other chemicals and 
reagents used were of analytical grade.  
Formulation And Administration of Fenugreek 
Fenugreek  powder  was  suspended  in  0.5%  carboxymethyl 
cellulose (CMC) and each animal belonging to three different 
groups  received  fenugreek  at  a  dose  of  250  mg/kg  body 
weight everyday respectively by intragastirc intubation
14. 
Induction of Myocardial Infarction 
Myocardial  infarction  was  induced  by  intraperitoneal  (i.p.) 
injection  of  isoproterenol  hydrochloride  85  mg/kg  body 
weight, dissolved in physiological saline, for two consective 
days (14
th and 15
th days)
15. 
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Experimental Animals 
The Wistar strain male albino rats, weighing 110-150g were 
selected for the study. They were housed in plastic cages with 
filter tops under controlled conditions of 12-h light/12-h dark 
cycles 50% humidity at 28°C. The animals were allowed a 
standard feed and water ad libitum. They were acclimatized 
to the environment for 1 week prior to experimental use. The 
study  was  conducted  after  obtaining  a  clearance  from  the 
institutional  animal  ethical  committee  (IAEC)  (Reg  .no: 
P.Col/52/2010/IAEC/VMCP)  of  Vinayaka  Mission  College 
of Pharmacy, Salem, Tamil Nadu. 
Treatment Schedule 
The rats were randomly divided into four groups of 6 rats 
each. Group 1 rats received 1.0ml of 0.5% carboxy methyl 
cellulose  (CMC)  throughout  the  experimental  period  and 
served  as  the  untreated  control.    Group  2  rats  received 
isoproterenol (85 mg/kg body weight) intraperitoneally twice 
at an interval of 24 hours on the 14
th and 15
th days. The rats 
in group 3 received fenugreek via intragastric intubation at a 
daily  dose  of  (250  mg/kg  body  weight)  respectively  for  a 
period  of  15  days.  Group  4  rats  received  fenugreek  as  in 
group  3 for 15 days and at the last of the experimental period 
on 14
th and 15
th  days rats received isoproterenol (85 mg/kg 
body weight) injections intraperitoneally twice at an intravel 
of 24 hours. The experiment was terminated after 15 days and 
all the animals were killed by cervical decapitation after an 
overnight fast. 
Preparation of Hemolysate 
Blood  was  collected  in  heparinized  tubes  and  plasma 
separated by centrifugation at 2000xg for 10min. After the 
separation  of  plasma,  the  buffer  coat  was  removed  and 
packed  cells  (erythrocytes)  were  washed  thrice  with  cold 
physiological saline. To determine the activity of erythrocyte 
antioxidant enzymes, haemolysate was prepared by lysing a 
known  volume  of  erythrocytes  with  hypotonic  phosphate 
buffer pH 7.4. The contents were then centrifuged at 3000xg 
for 10min at 2˚C to separate the haemolysate. 
Preparation of Tissue Homogenate 
Heart tissue were removed immediately and washed with ice-
cold saline and homogenized in the appropriate buffer in a 
tissue homogenizer. 
Biochemical Estimation 
Hemoglobin  was  determined  by  the  method  of  Drabkin
15.
 
Hemoglobin was oxidised to methaemoglobin that combines 
with  cyanide  to  form  cyanomethaemoglobin  that  was 
measured  at  540  nm.  The  amount  of  hemoglobin  was 
expressed  as  mg/dl  blood.  Lipids  from  the  tissues  were 
extracted  by  the  method  of  Folch
16.  Total  cholesterol  was 
determined  by  the  method  of  Zlatkis
17.  Lipid  extract  was 
treated with ferric chloride acetic-acid reagent to precipitate 
the proteins. The protein free supernatant was treated with 
concentrated H2SO4 a reddish purple colour formed was read 
in  a  Spectronic  20  colorimeter  at  560  nm.  Values  are 
expressed as mg/100 g tissue or mg/dl. Phospholipids were 
determined by the method of Zilversmit
18. The formation of 
stable blue colour, which was read in a colorimeter at 680 
nm. The amounts of phospholipids are expressed as mg/100 g 
tissue or mg/dl. Triglycerides were determined by the method 
of Foster
19.  The absorbance of yellow coloured compound 
was  read  in  a  Spectronic  20  colorimeter  at  405  nm.  The 
triglyceride content is expressed as mg/100 g tissue or mg/dl. 
Free fatty acids were determined by the method of Falholt
20. 
Non-esterified free fatty acids were estimated by the method 
of copper soap formation Falholt
20. The amounts of free fatty 
acids are expressed as mg/100 g tissue or mg/dl. 
Activities of AST and ALT were assayed by the method of 
Reitman
22.  The  liberated  oxaloacetate  and  pyruvate  reacts 
with 2, 4-dinitrophenyl hydrazine to form 2, 4-dinitrophenyl 
hydrazone, which was read at 540 nm. Activities of aspartate 
and   alanine   transaminase were expressed as IU/L. The 
activity  of  lactate  dehydrogenase  (LDH)  was      assayed  in 
serum using a commercial kit (Product No. 72351) purchased 
from   Qualigens Diagnostics, Mumbai, India. The enzyme 
activity  was  expressed  as  IU/L  for  serum  and  nmol  of 
pyruvate liberated/min/mg protein for tissue. Creatine kinase 
activity  was  assayed  by  the  method  of  Okinada
23.  The 
enzyme activity was expressed as IU/L for serum and µmoles 
of phosphorus liberated/min/mg protein for tissue. Creatine 
kinase-MB activity was assayed in serum using a commercial 
kit  (Product  No.  11207001)  obtained  from  Agappe 
Diagnostics, Kerala, India. The enzyme activity in serum was 
expressed as IU/L. 
Statistical Analysis 
The data presented here are means ± standard deviation of 6 
rats in each group. The results were analyzed using one-way 
analysis  of  variance  [ANOVA] and the  group  means  were 
compared by Duncan’s Multiple Range Test [DMRT] using 
SPSS version 12 for windows. The findings were considered 
as statistically significant if P<0.05
24.   
RESULTS 
Table 1 represents the effect of fenugreek on cardiac marker 
enzymes (AST, ALT, CK, LDH and CK-MB) of control and 
experimental rats.  Circulating levels of AST, ALT, CK and 
LDH  status  were  significantly  increased  except  CK-MB 
showed decreased levels on isoproterenol treated rats (group 
2) as compared to the control rats (group1). The activities of 
marker  enzymes  (AST,  ALT,  CK  and  LDH)  were  near to 
control rats treated with fenugreek (group 3) as compared to 
untreated  control  rats  (group  1),  and    fenugreek  + 
isoproterenol treated rats (group 4)  significantly decreased 
the  levels  of  marker  enzymes  (AST,ALT,CK  and  LDH  ) 
except  CK-MB  increased    as  compared  to  the 
unsupplemented isoproterenol treated rats.  
Table  2  represents  the  effect  of  fenugreek  on  serum  lipid 
metabolism  of  control  and  experimental  rats.  Circulating 
levels  of  triglyceride,  cholesterol  and  free  fatty  acids  were 
significantly increased in isoproterenol treated rats were as 
phospholipids  was  significantly  decreased  (group  2)  as 
compared  to  the  control  rats  (group  1).  The  activities  of 
triglyceride,  cholesterol,  free  fatty  acids  and  phospholipids 
were near to control rats treated with fenugreek (group 3) as 
compared to untreated control rats (group 1), and fenugreek + 
isoproterenol  treated  rats  (group  4)  significantly  decreased 
the  levels  of  triglyceride  cholesterol  and  free  fatty  acids 
whereas  phospholipids  were  significantly  increased  as 
compared  to  the  unsupplemented  isoproterenol  treated  rats 
(group 2). 
Table  3  represents  the  effect  of  fenugreek  on  tissue  lipid 
metabolism of control and experimental rats. Tissue levels of 
triglyceride,  cholesterol  and  free  fatty  acids,  were 
significantly  increased  except  phospholipids  showed 
decreased activity in isoproterenol treated rats (group 2) as 
compared  to  the  control  rats  (group  1).  The  activities  of 
triglyceride,  cholesterol,  free  fatty  acids  and  phospholipids 
were near to control rats treated with fenugreek (group 3) as 
compared  to  untreated  control  rats  (group  1),  whereas 
fenugreek + isoproterenol treated rats (group 4)  significantly 
decreased the levels of triglyceride, cholesterol, and free fatty 
acid  except  phospholipids  increased  as  compared  to  the 
unsuplemented isoproterenol treated rats (group 2). Vaiyapuri Manju et al. IRJP 2012, 3 (2) 
Page 213 
Table  4  shows  the  effect  of  fenugreek  on  lipoproteins 
(VLDL, LDL and HDL) of control and experimental animals. 
Circulating  levels  of  lipoprotein  VLDL  was  significantly 
increased except HDL and LDL showed decreased levels in 
isoproterenol treated rats (group 2) as compared to the control 
rats  (group  1),  The activities  of  lipoproteins  (VLDL,  LDL 
and HDL) were near to control rats treated with fenugreek 
(group 3) as  compared to  untreated  control rats  (group  1), 
whereas the activity of lipoprotein VLDL was significantly 
decreased except HDL and LDL showed increased levels in 
fenugreek + isoproterenol induced rats (group 4) as compared 
to untreated isoproterenol treated rats (group 2).  
DISCUSSION 
Myocardial Infarction (MI) is a major public health concern 
and common presentation of ischemic heart disease. It is a 
clinical  syndrome  arising  from  sudden  and  persistent 
curtailment of myocardial blood supply resulting in necrosis 
of  the  myocardium.  This  is  followed  by  numerous 
pathophysiology  and  biochemical  changes  such  as  lipid 
peroxidation, elevated levels of cardiac markers, altered lipid 
profile,  etc
25.  Although  clinical  care  is  improved,  public 
awareness is raised and health innovations are widely used, 
myocardial infarction still remains the leading cause of death 
worldwide
26.  In  India,  the  number  of  patients  being 
hospitalized for myocardial infarction, commonly known as 
heart attack, is increasing over the past 35 years and male 
patients have shown a more striking increase
27. Myocardial 
cell protection and prevention of cell ischemia/necrosis have 
been therapeutic targets for a long time. New therapies are 
needed  to  treat  myocardial  ischemia  because  current 
treatment has only a limited impact on survival and annual 
costs.  
ISO  can  produce  excessive  free  radicals  resulting  from 
oxidative  metabolism  of  catecholamines
28.  ISO-induced 
myocardial  ischemia  has  been  reported  to  show  many 
metabolic  and  morphologic  aberrations  in  experimental 
animals similar to those in humans
6. Therefore ISO is widely 
used  as  an  agent  to  evaluate  the  effect  of  drugs  in  the 
myocardial  consequences  of  ischemic  disorders
30.  In  the 
present  study,  with  the  focus  on  the  protective  effects  of 
fenugreek  against  isoproterenol  induced  myocardial 
infarction  in  rats.  We  showed  that  pre-treatment  with 
fenugreek  could  prevent  myocardial  infarction  induced  by 
ISO in the rats. 
Cytosolic  enzymes  CK-MB,  LDH,  AST  and  ALT,  which 
serve as the diagnostic markers leak out from the damaged 
tissue  to  blood  stream  when  cell  membrane  becomes 
permeable or rupture
31. The amount of these cellular enzymes 
in serum reflects the alterations in plasma membrane integrity 
and/or permeability
32.  
In the present study, we observed significant increase in the 
activities of enzymes such as ALT, AST, LDH and CK and 
decrease in the activity of CK-MB on isoproterenol induced 
myocardial  infarction  rats  due  to  the  damage  in  the  heart 
muscle, rendering the leakage of enzymes into the serum. An 
increased level is an indication of the severity of the necrotic 
damage  to  myocardial  membrane.  The  amount  of  cardiac 
enzymes in serum is proportional to the number of necrotic 
cells
33. Earlier reports suggested that these enhanced levels of 
specific  marker  enzymes  might  be  due  to  enhanced 
susceptibility  of  myocardial  cell  membrane  to  the 
isoproterenol  mediated  peroxidative  damage
34.  Decreased 
level  of  CK-MB  is  observed  in  isoproterenol  induced 
myocardial infarction rats. CK-MB is a marker of myocyte 
injury  or  death,  leaks  out  from  myocardium  due  to 
disintegration  of  the  contractile  elements  and  increased 
sarcoplasmic  permeability
35.  Increased  level  of  lipid 
peroxidation  with  concomitant  fall  in  CK-MB  activity 
indicates the isoproterenol induced myocardial damage. 
Fenugreek administration significantly declines the level of 
myocardial injury and restored the levels of the diagnostic 
marker enzymes to control rats. Fenugreek reduced the extent 
of myocardial damage and there by restricted the leakage of 
these enzymes from myocardium. The levels of CK-MB also 
restored to normal level in fenugreek administered rats and 
this  might  be  due  to  the  preservation  of  myofibrils  and 
mitochondrial morphology. The results of the present study 
showed the cardioprotective activity of fenugreek. 
Lipids play an important role in cardiovascular diseases, not 
only  by  way  of  hyperlipidemia  and  the  development  of 
atherosclerosis,  but  also  by  modifying  the  composition, 
structure and stability of the cellular membranes. High level 
of  circulating cholesterol and its accumulation in the heart 
tissue is usually accompanied by cardiovascular damage
36. 
In the present study, the total cholesterol, triglycerides, free 
fatty  acids  and  phospholipids  were  observed  in  serum  and 
heart  of  ISO  induced  rats.  Strong  evidence  suggested  that 
hypercholesterolemia  induces  oxidative  stress  by  causing a 
reduction in the enzymatic antioxidant defence potential of 
tissues and generation of oxygen free radicals like superoxide 
anions.  As  a  result  of  these  metabolic  events  peroxidation 
reactions  are  accelerated  leading  to  cellular  injury
37. 
Previously  it  has  been  reported  that  the  increase  in  the 
myocardial cholesterol content in ISO induced rats is due to 
increased  uptake  of  low  density  lipoprotein  (LDL)-
cholesterol from the blood by myocardial membranes
38.  
Treatment  with  fenugreek  decreased  the  levels  of  TGs  in 
myocardial infarcted rats under severe ischemic conditions. 
Thus,  circulating  FFAs  may  be  increased  in  myocardial 
infarcted rats. Earlier report showed that increased levels of 
blood  FFAs  may  depress  cardiac  function,  promote 
arrhythmias  and  further  increase  the  extent  of  myocardial 
damage
39, 40 also reported that after addition of catecholamine 
to  heart  homogenate  resulted  in  the  release  of  FFAs. 
Although lipid availability is important for the heart, excess 
levels of fatty acids in myocytes can be deleterious
41.  
Treatment  with  fenugreek  lowered  the  levels  of  FFAs  in 
myocardial infarcted rats. Membrane PLs are essential factors 
in  maintaining  cell  function  and  degradation  of  PLs  by 
phospholipase  and  other  phospholipases  have  been 
implicated as a vital factor in the genesis of ischemic cellular 
injury
42.  Previous  findings  reported  that  ISO  increases  the 
activity  of  phospholipase.  Thus,  the  observed  decreased 
content  of  PLs  in  ISO  induced  myocardium  is  due  to 
accelerated  membrane  degradation  of  PLs  by 
phospholipases
43. 
Treatment  with  fenugreek  showed  a  stabilizing  effect  on 
myocardial phospholipids. This may be due to the ability of 
fenugreek  to  prevent  peroxidation  of  membrane 
phospholipids.  Isoproterenol  administration  raised  LDL 
cholesterol and decreased HDL cholesterol level in the serum 
(Table  4).  Interestingly,  treatment  with  fenugreek  reversed 
the  effects  of  isoproterenol  that  reduced  total  cholesterol, 
LDL cholesterol and increased HDL cholesterol that clearly 
pointed out the restoring capacity of fenugreek on MI
36. 
Isoproterenol induced rats also showed an increase in LDL 
fraction  along  with  a  decrease  in  HDL-cholesterol. 
Phospholipids were found to be decreasing in the heart and 
increasing in the serum of isoproterenol induced rats. These 
changes could be attributed to enhanced lipid biosynthesis by Vaiyapuri Manju et al. IRJP 2012, 3 (2) 
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cardiac cyclic adenosine monophosphate
44. A strong positive 
correlation  has  been  documented  between  the  risk  of 
developing  ischemic  heart  disease  and  serum  LDL  level, 
whereas a negative correlation has been reported with HDL-
cholesterol
45. Earlier reports suggested that ISO-treated rats 
showed an increase in serum phospholipids, which may be 
due to an increased peroxidation of membrane phospholipids 
released via phospholipase A2
46 and also reported an increase 
in serum phospholipids in ISO-treated rats. Free fatty acids 
are  substances  for  microsomal  lipid  peroxidation
47.  The 
higher levels of serum free fatty acids in animals treated with 
ISO are due to increased lipolysis
48. On pre-treatment with 
fenugreek  successfully  restored  the  elevated  triglycerides, 
LDL-cholesterol and phospholipid levels in serum and also 
restored the total cholesterol and phospholipid levels in the 
heart in the fenugreek treated group. 
Administration  of  fenugreek  to  isoproterenol  induced 
myocardial  infarction  in  rats  were  restored  the  levels  of 
phospholipids, cholesterol, free fatty acids, triglycerides and 
lipoproteins  (LDL,  VLDL  and  HDL)  as  compared  to 
unsupplemented isoproterenol induced rats. It also maintains 
the levels of HDL cholesterol, VLDL and LDL cholesterol in 
plasma and tissue at a concentration comparable to that of 
group  1  rats.  Fenugreek  supplementation  was  effective  in 
lowering VLDL and LDL cholesterol levels in experimental 
animals. This may be due to the hypocholesteremic effect
49 
of  fenugreek.  The  cardioprotective  activity  of  fenugreek 
could  be  related  to  the  ability  to  inhibit  the  increased 
accumulation of lipids due to its antilipidimic property. 
CONCLUSION  
It is clear that pretreatment with fenugreek normalized the 
levels of lipids and cardiac marker enzymes in ISO induced 
MI  in rats. This  could  be  due  to  the  antioxidant  effect  of 
fenugreek. This is an indication that the species could be used 
for the treatment of cardiac related diseases.  
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Table 1- Effect of fenugreek on marker enzymes of control and experimental rats 
 
The results are expressed as mean ± SD of ten rats in each group. 
ap<0.05 when compared with normal, 
bp<0.05 when compared with isoproterenol 
 
Table 2- Effect of fenugreek on serum lipid metabolism of control and experimental rats 
Groups  Normal control  Isoproterenol 
(85 mg/kg) 
Fenugreek 
(250mg/kg) 
Fenugreek (250 mg/kg) + 
isoproterenol (85 mg/kg) 
Triglyceride (IU/L)  132±0.16  181±0.19
a  119±0.20  143±0.26
b 
Cholesterol (IU/L) 
76±0.25  115±0.27
a  56±0.35  85±0.32
a 
Free fatty acids (IU/L) 
24.2±0.14  37.6±0.19
a  20.2± 0.19  32.9±0.24
b 
Phospholipids (IU/L)  80.2±6.92  61.2±3.84
a  82.2±6.32  76.2±6.41
b 
 
The results are expressed as mean ± SD of ten rats in each group. 
ap<0.05 when compared with normal, 
bp<0.05 when compared with isoproterenol 
 
Table 3- Effect of fenugreek on heart tissue lipid metabolism of control and experimental rats 
Groups  Normal control  Isoproterenol 
(85 mg/kg) 
Fenugreek 
(250mg/kg) 
Fenugreek (250mg/kg) + (isoproterenol 
(85 mg/kg) 
 
Triglyceride (IU/L)  3.3±0.16  5.42±0.45
a  2.51±0.20  2.9±0.26
b 
 
Cholesterol (IU/L)  2.52±0.19  3.55±0.30
a  2.48±0.13  2.7±0.32
b 
 
Free fatty acids (IU/L) 
 
4.1±0.14  5.6±0.19
a  2.6± 0.19  4.3±0.24
b 
 
Phospholipids (IU/L)  13.27±1.25  9.68±0.76
a  14.3±0.89  12.1±1.21
b 
 
The results are expressed as mean ± SD of ten rats in each group. 
ap<0.05 when compared with normal, 
bp<0.05 when compared with isoproterenol 
 
 
 
Groups  Normal control  Isoproterenol 
(85 mg/kg)  Fenugreek (250mg/kg)  Fenugreek (250 mg/kg) + 
isoproterenol (85 kg/kg) 
AST (IU/L) 
  25.5± 0.34  53.2±0.39
a  20.6±0.25  39.9±0.42
b 
ALT (IU/L) 
 
13.2±1.80  24.8±0.54
a  11.9±1.02  17.8±0.56
b 
LDH (IU/L) 
  83.2±0.03  158.5±0.02
a  60.2±0.03  118.1±0.026
b 
CK (IU/L) 
  135.5±0.58  189.2±0.138
a  120.2±0.157  150.3±0.11
b 
CK-MB (IU/L) 
162.2± 0.19  80.1±0.23
a  165.5±0.24  145.5±0.25
b Vaiyapuri Manju et al. IRJP 2012, 3 (2) 
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Table – 4 Effect of fenugreek on serum lipoproteins of control and experimental rats 
Groups  Normal control  Isoproterenol   
(85 mg/kg) 
Fenugreek 
(250mg/kg) 
Fenugreek (250mg/kg) + (isoproterenol 
(85 mg/kg) 
 
HDL (IU/L)  50.37± 0.26  30.45 ± 0.26
b  54.43 ± 0.29  46.45 ± 0.26
b 
 
LDL (IU/L)  68.2 ± 0.46  40.52 ± 0.29
b  51.46 ± 0.30  58.28 ± 0.50
b 
  
 VLDL (IU/L)  20.51± 0.29  28.37 ± 0.35
b  15.52 ± 0.27  21.54 ± 0.23
b 
The results are expressed as mean ± SD of ten rats in each group. 
ap<0.05 when compared with normal, 
bp<0.05 when compared with isoproterenol 
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